Apr 20, 2025, 19:38

ACS: Extramural Discovery Science Accelerator Award

The Extramural Discovery Science Accelerator Award supports the commercialization of ongoing cancer research projects by funding critical experiments that help validate and de-risk technologies. Proposals must focus on a defined, commercially driven aim such as dosing, toxicity, or efficacy testing, and applicants must plan to license the technology to a start-up or established company if successful. This mechanism is not intended to launch new research directions.

Eligibility

Independent investigators with full-time faculty appointments (or equivalent) at eligible US institutions
Applicants may be at any career stage
Must be motivated to commercialize a specific ongoing research project
No prior ACS funding required

Grant Term and Budget

75,000 USD total costs for a 1-year project
Indirect costs are not allowed

Application Timeline

Rolling submission
Applications submitted by June 1 will be reviewed in July (grants start September 2025)
Applications submitted after June 1 will be reviewed in December (grants start April 2026)
Applications must be submitted within 1 month of initiation on ProposalCentral

(If the deadline falls on a weekend or holiday, the next business day applies)

Program Contact

Doug Hurst, PhD
Email: [email protected]

American Cancer Society biotech innovation cancer cancer research funding commercialization Doug Hurst drug development Extramural Discovery Science Accelerator Award OncoDaily Oncology oncology research research commercialization technology transfer Translational Oncology

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More